Malaria control in East Africa: the Kampala Conference and the Pare-Taveta Scheme: a meeting of common and high ground.

The 1950 Malaria Conference in Equatorial Africa, held in Kampala, Uganda, has been remembered primarily for its decision to control malaria '...by modern methods as soon as feasible, whatever the original degree of endemicity, and without awaiting the outcome of further experiments.' This decision was far from conclusive and, indeed, reflects only one side of the argument which brought two groups of malariologists into direct opposition on the wisdom of malaria control in equatorial Africa, using modern methods such as DDT. Through an examination of the unpublished verbatim transcript of the Kampala Conference, we are able to document the 'furious debates' which took place at Kampala in 1950. We highlight, in particular, the adamant concerns expressed by some of the delegates that intervention in areas of high malaria transmission might lead to a loss of naturally acquired immunity which, in turn, could give rise to a resurgence of malaria, should the control strategies fail to be sustained. As we show, this concern had been expressed by a number of malariologists working in East Africa in the first half of the twentieth century, but it was only with the advent of DDT, as a residual insecticide, that the implications of wide-spread control, in the absence of any knowledge of the long-term consequences, became a serious possibility. While the Kampala Conference gave the 'go ahead' to control malaria in Africa without awaiting the outcome of 'further experiments', a number of participants insisted that a field trial should be set up to evaluate the impact of malaria on areas of high transmission both before and after spraying: to this end, a field trial in Pare-Taveta was carried out in 1954-59. In this paper we look at the Kampala Conference for its scientific debates and the Pare-Taveta Scheme for its field applications. In the final part of the paper, we address a number of questions raised at Kampala which have, once more, become contentious issues, following the recent successful trials of ITBNs. We believe that an understanding of the historical foundations of these issues should provide an important component of the new WHO campaign to Roll Back Malaria.

THE EAST AFRICAN MEDICAL JOURNAL: ITS HISTORY AND CONTRIBUTION TO REGIONAL MALARIA RESEARCH DURING THE LAST 75 YEARS.

Since its inception seventy five years ago, the East African Medical Journal has provided an uninterrupted forum through which medical practitioners and scientists could publish their research. Although the EAMJ was initially prepared for an audience of colonial medical officers, by the 1930s the journal expanded to include subscription and submissions from Northern Rhodesia (now Zimbabwe) and West Africa. Our review begins with a history of the journal's production, exploring the shifts in editorial composition. We then focus more directly on a discussion of papers and editorials on malaria, a disease that continues to challenge the region of East Africa. Our review highlights the importance of the journal's commitment to publications on this major health problem within the East African environment. Of particular interest, our review shows that many of today's concerns, debates and recommendations for control or treatment of malaria in East Africa were discussed and debated in earlier issues of the EAMJ. Medical policy for the region with regard to malaria will benefit from revisiting previous volumes of the EAMJ. These contributions will ensure the journal a significant place in the world of research publications for the coming seventy five years.

Yersinia enterocolitica: biochemical, serological, and gas-liquid chromatographic characterization of rhamnose-, raffinose-, melibiose-, and citrate-utilizing strains.

Thirteen atypical Yersinia enterocolitica isolates, all fermenting rhamnose, raffinose, and melibiose and utilizing sodium citrate within 24 to 48 h at 22 degrees C (Y.e.rh+), were examined biochemically-serologically, and by gas-liquid chromatography. These data, as well as cultural, biochemical, and antibiotic susceptibility data gathered from two previous studies involving (i) these same atypical Y.e.rh+ isolates, (ii) Y. enterocolitica serotypes O:1 through O:15 (rhamnose, raffinose, and citrate negative [Y.e.rh-]), (iii) Y. enterocolitica serotype O:16 (rhamnose positive but raffinose and citrate negative), and (iv) Yersinia pseudotuberculosis serogroups I through V were statistically compared. Both preand postabsorption agglutination studies demonstrated the serological distinctiveness of Y.e.rh+ from Y.e.rh- and Y. pseudotuberculosis. At the same time, three immunological groups among the 13 Y.e.rh+ strains were seen; 8 corresponded to Y. enterocolitica serotype O:17; 1 to Y. enterocolitica serotype O:16; and the remaining four were nontypable in antisera against known Y. enterocolitica antigen types. Each of the three Yersinia groups tested chromatographically produced acetic and lactic acids. Both Y.e.rh- and Y.e.rh+ formed propionic acid, but only Y.e.rh+ produced detectable amounts of succinic acid. Based on 49 variables, statistical analysis of the three Yersinia groups studied placed each of the Y.e.rh+ strains in a homogeneous group separate from both Y.e.rh- and Y. pseudotuberculosis. These data, coupled with deoxyribonucleic acid homology studies of Brenner and co-workers (D. J. Brenner, A. G. Steigerwalt, D. F. Falcao, R. E. Weaver, and G. R. Fanning, Int. J. Syst. Bacteriol. 26:180-194, 1976), support the distinctiveness of Y.e.rh+ from typical Y. enterocolitica and Y. pseudotuberculosis.

Unusual Yersinia enterocolitica isolates not associated with mesenteric lymphadenitis.

Thirteen Yersinia enterocolitica were recovered from a variety of clinical sources. Of these, only one was associated with mesenteric lymphadenitis and belonged to serotype 8. The 12 remaining strains were isolated from nonmesenteric sources and belonged to serotype 17. All strains exhibited the main characteristics of Y. enterocolitica which differentiated them from other Enterobacteriaceae, i.e., motility at 22 C but not at 37 C, positive urease and ornithine decarboxylase activities, and negative phenylalanine deaminase. These 12 strains differed, however, from other Y. enterocolitica previously described in the United States in that they fermented rhamnose and raffinose at 22 C, and failed to grow on Salmonella-Shigella and Hektoen-Enteric agars.

Contribución al estudio de la incidencia de tipos de Shigella flexneri en nuestro país / Contribution to the study of type incidence of shigella flexneri in our country

Se reporta el estudio serológico de 29 cepas de Shigella flexneri aisladas de hospitales de la Habana y del Laboratorio de la Regional de la Provincia, habiéndose encontrado una incidencia mayor del 2a-11 cepas-y del la-6 cepas-.....(AU)

Shígelosis del lactante por s. flexneri tipo 6

Se presenta el estudio bacteriológico de una cepa de Shigella B tipo 6 variedad Boyd 88 aislada de un lactacte.....(AU)